| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Inc / Ma (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.48M | - | |
| COO | 63.4K | $28.71M | - | |
| VP | 51.1K | $23.14M | - | |
| VP | 42.3K | $19.16M | - | |
| Other | 24.0K | $10.89M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Wagner Charles F Jr50 | EVP &Chief Financial Officer | Sell | 3,000 | $405.00 | $1,215,000.00 | -6.4% | +2.3% | -1.3% | |
| Dec 15, 2023 | Kewalramani Reshma55 | CEO &President | Sale+OE | 17,135 | $407.00 | $6,973,945.00 | -13.6% | -0.5% | +12.9% | |
| Dec 13, 2023 | Leiden Jeffrey M47 | Executive Chairman | Sell | 13,354 | $399.42 | $5,333,799.14 | -42.3% | +1.8% | +14.6% | |
| Dec 13, 2023 | Kewalramani Reshma55 | CEO &President | Sell | 5,098 | $397.00 | $2,023,906.00 | -4.5% | +1.8% | +14.6% | |
| Dec 13, 2023 | Arbuckle Stuart A | EVP, COO | Sale+OE | 8,603 | $399.00 | $3,432,597.00 | -13.2% | +1.8% | +14.6% | |
| Nov 20, 2023 | Wagner Charles F Jr50 | EVP &Chief Financial Officer | Sell | 3,000 | $349.88 | $1,049,640.00 | -6.0% | +17.9% | +25.5% | |
| Nov 15, 2023 | Sachdev Amit | EVP Chief Patient &Ext Af Off | Sell | 35 | $369.92 | $12,947.20 | - | +19.1% | +38.5% | |
| Nov 15, 2023 | Altshuler David48 | EVP, Global Research And CSO | Sell | 19 | $369.92 | $7,028.48 | - | +19.1% | +38.5% | |
| Nov 14, 2023 | Bozic Carmen53 | EVP And CMO | Sell | 5,650 | $380.82 | $2,151,633.00 | -16.2% | +13.1% | +33.7% | |
| Nov 13, 2023 | Kewalramani Reshma55 | CEO &President | Sell | 5,097 | $377.00 | $1,921,569.00 | -4.3% | +10.5% | +29.3% |